Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
BioInvent International - What the Logo?
BioInvent International 2026 Company Profile: Stock Performance ...
BioInvent Virtual KOL Event to highlight recently presented efficacy ...
Logos Download | BioInvent International
BioInvent Logo Vector Free Download | Logowik
BioInvent
BioInvent International aktie (BINV) - Dagens industri
BioInvent International aktie och bolag (BINV), nyheter, riktkurser
BioInvent International AB Publishes Annual Report 2022 - BioSpace
Annual reports | BioInvent
BioInvent International AB publishes Annual Report 2023 | BioInvent
Video & interview archive | BioInvent
Transgene and BioInvent to Present Translational Data and
BioInvent Virtual KOL Event to Discuss BI-1808 for the Treatment of ...
Investors | BioInvent
Homepage | BioInvent
BI-1607 | BioInvent
Status report - BioInvent breaks new ground in immuno-oncology - Biostock
Merck mejora la capacidad de producción de BioInvent con los ...
Pipeline | BioInvent
BI-1910 | BioInvent
BioInvent International AB - A Company At Ideon
BioInvent International AB on LinkedIn: #immunotherapy #immunooncology ...
Bioinvent Aktie 2026 - BINV.ST - Webinvestor.io
BioInvent International – Aktiedagarna Stockholm 18 september 2024 ...
BioInvent International | The Org
Technology | BioInvent
Manufacturing | BioInvent
About Us | BioInvent
Bioinvent shifts into higher gear - Biostock
Working at BioInvent | BioInvent
CRT & BioInvent collaborate to develop new cancer treatments
Transgene and BioInvent to Present Updated Data on Armed Oncolytic ...
Lund based BioInvent has had a busy week with a presentation of one ...
#biotechnologyindustry #mabs #development #lifesciences | BioInvent ...
BioInvent Extends Collaboration for the Discovery and Development of ...
Happy to announce that BioInvent has launched a new website ...
BioInvent kursraketten har stadig potentiale | Økonomisk Ugebrev
BioInvent $BINV.ST Looks like BioInvent’s BI-1808 might be one of few ...
Preclinical Programs | BioInvent
Startsida | BioInvent
New clinical data from BioInvent - NLS
BioInvent International aktie - information och data om aktien
SAVE THE DATE - BioInvent to host R&D Day in Stockholm on December 8 ...
Martin Welschof, CEO of BioInvent will be presenting the company this ...
Our History | BioInvent
Our Operations | BioInvent
Scientific publications | BioInvent
BioInvent på tærsklen til vigtige kliniske data | Økonomisk Ugebrev
#nbdi2026 | BioInvent International AB
BioInvent International AB on LinkedIn: #immunooncology #immunotherapy ...
Contact | BioInvent
BIOINVENT | Patent Attorneys & Translators | LinkedIn
BioInvent International: A Promising Biotech Stock with a Strong Pipeline
📢 Transgene et BioInvent International AB sont fières d’annoncer une ...
BioInvent extends research collaboration with Pfizer
Bioinvent AB licences BI-1206 to CASI Pharmaceuticals - European ...
BioInvent achieves milestone for BI-1808 - Biostock
Investerare | BioInvent
BioInvent prepares for a data-rich 2025 - Biostock
BioInvent offentliggör prospekt avseende företrädesemission och riktad ...
BioInvent International (BINV) aksje | Nordnet
BioInvent Download png
Bioinvent svg eps | UIDownload
Merck fournit des installations de fabrication améliorées à BioInvent ...
Bioinvent Aktie - Aktiekurser & Nyheder 2026 - Webinvestor.dk
BioInvent Announces Initiation of BI-1206 Phase 2a Trial in Advanced or ...
BioInvent Receives Clinical Milestone in Partner Program
Bioinvent AB investor | Facebook
BioInvent – Connect
Biotech Companies - Medicon Valley Alliance
Revolutionizing Cancer Care: The Breakthrough BT-001 Oncolytic Virus ...
Bioinvent: "We have four programs ongoing" - Pareto Securities
治疗实体瘤,溶瘤病毒BT-001的1a期数据积极!_摩熵医药(原药融云)
#immunooncology #immunotherapy #therapeuticantibodies #ctcl # ...
Accelerating Target Deconvolution for Therapeutic Antibody Candidates
#sachs_elsf #lifesciences #biotechineuropeforum #europeanbiotech # ...
#immunooncology #immunotherapy #antibodytherapeutics #biotechnology # ...
#immunooncology #hematologyoncology #therapeuticantibodies # ...
#immunooncology #immunotherapy #singleagentactivity # ...
BioInvent's BI-1808: A New Hope for Cutaneous T Cell Lymphoma?
#antibodytherapeutics #antibodydiscovery #biotechnologyindustry ...
BioInvent’s ASCO Presentation Could Validate or Crush Its TNFR2 ...
#immunooncology #immunotherapy #biotechnology #antibodytherapeutics ...
BioInvent’s Fast Track Milestone: A Breakthrough for CTCL Patients and ...
@agingroy Have you seen BioInvent’s BI-1808 ASCO poster? Small-cap ...
BioInvent's CMO comments on phase I/IIa data with BI-1808 - Biostock
#eha2024 #immunotherapy #immunoncology #antibodytherapeutics # ...
Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive ...
Transgene – L'immunothérapie contre les cancers